Stay updated on Nivolumab for Peripheral T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous revision label. This signals a minor update to the study record metadata without altering the study data or main content.
    Difference
    0.0%
    Check dated 2026-05-14T23:07:31.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.5.2 to v3.5.3, indicating an incremental update to the site software. This change is a metadata-level modification and does not affect the study details or visible content.
    Difference
    0.0%
    Check dated 2026-04-30T16:48:48.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a minor patch with no changes to core page content.
    Difference
    0.0%
    Check dated 2026-04-16T10:39:27.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added Extranodal nasal NK/T cell lymphoma and CD4+/CD56+ hematodermic neoplasm to the study's listed conditions.
    Difference
    0.1%
    Check dated 2026-04-02T00:11:08.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page.
    Difference
    0.0%
    Check dated 2026-03-25T20:27:23.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T11:37:34.000Z thumbnail image

Stay in the know with updates to Nivolumab for Peripheral T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.